Linkedin
  • phone (+48) 71 325 62 42
Search

Publications and conferences

Publications

  1. M. Litwin, A. Szczepańska-Buda, A. Piotrowska, P. Dzięgiel, W. Witkiewicz: The meaning of PIWI proteins in cancer development (Review). Oncology Letters 2017 Vol.13; s.3354-3362 – see details
  2. P. Paduszyński, T. Krusiński, T. Han, W. Musiał: Early stage of drug release non-classified in BCS influenced by coating excipients: hydroxypropyl methylcellulose and polyvinyl alcohol. Lat. Am. J. Pharm. 2016 Vol.35 no.1; s.84-90 – see details
  3. K. Klimek, A. Belcarz, R. Pazik, P. Sobierajska, T. Han, R.I. Wiglusz, G. Ginalska: ”False” cytotoxicity of oins- adsorbing hydroxyapatite – Corrected method of cytotoxicity evaluation for ceramics of high specific surface area. . Material Science and Engineering C 2016 Vol.65; s.70-79 – see details
  4. T. Han, R. Petrus, D. Bykowski, L. Jerzykiewicz, P. Sobota: Synthesis and Structural Characterization of Magnesium Drug Complexes: Efficient Initiators for Forming Polylactide-Drug Conjugates. Organometallics 2015 Vol.34 no.20; s.4871-4880 – see
  5. E. Burchacka, P. Potaczek, P. Paduszyński, K. Karłowicz-Bodalska, T. Han, S. Han: New effective azelaic acid liposomal gel formulation of enhanced pharmaceutical bioavailability. Biomed.Pharmacother. 2015 Vol.83; s.771-775 – see details
  6. S. Han, K. Karłowicz-Bodalska, P. Potaczek, A. Wójcik, Ł Ozimek, D. Szura, W. Musiał: Identification of unknown impurity of azelaic acid in liposomal formulation assessed by HPLC-ELSD, GC-FID, and GC-MS. AAPS Pharm. Sci.Tech. 2014 Vol.15 no.1; s.111-120 – see details
  7. D. Szura, Ł. Ozimek, M. Przybyło, K. Karłowicz-Bodalska, E. Jaźwińska-Tarnawska, A. Wiela-Hojeńska, S. Han: The impact of liposomes on transdermal permeation of Naproxen – in vitro studies. Acta Pol.Pharm. . 2014 Vol.71 no.1; s.145-151 – see details
  8. M. Kosińska-Klähn, Ł. John, A. Drąg-Jarząbek, J. Utko, R. Petrus, LB. Jerzykiewicz, P. Sobota: Transformation of barium-titanium chloro-alkoxide compound to BaTiO3 nanoparticles by BaCl2 elimination. Inorg. Chem. 2014 Vol.53 no.3; s.1630–1636 – see details
  9. P. Paduszyński, K. Dubas, K. Karłowicz-Bodalska, S. Han, W. Musiał: Influence of pH conditions and the type of measurement device on the release rate of clozapine from commercially available 100 mg tablets. Lat. Am. J. Pharm. 2014 Vol.33 no.3; s.447-452 – see details
  10. S. Han, K. Karłowicz-Bodalska, D. Szura, Ł. Ozimek, W. Musiał: Application of HPLC with ELSD detection for the assessment of azelaic acid impurities in liposomal formulation. Sci. World J.(online) 2013 Vol.2013; art.ID 564962[7 s.], doi:10.1155/2013/564962 – see details
  11. . T. Han, J. Utko, L.B. Jerzykiewicz, P. Sobota: Design of a magnesium- pridinolum complex for polylactide- drug conjugates formation. Dalton Trans. 2012 Vol. 40; s. 12660-12662 – see details 12660-12662
  12. A. Czogalla: Oral cyclosporine A the current picture of its liposomal and other delivery systems. Cell. Mol. Biol. Lett. 2009 Vol.14; s.139-152 – see details

Conferences

  1. 2nd Scientific Congress of the Polish Society of Medical Biology, 11th Scientific &Training Conference of the Immunotoxicology and Immunomodulation Division of the Polish Society of Experimental and Clinical Immunology “21st CENTURY MEDICINE”. Kościelisko-Zakopane 2016
  2. 2nd Congress BIO2016, 2nd Congress of Polish Biochemistry, Cell biology, Biotechnology and Bioinformatics – „Expanding beyond the limits”, Wroclaw, 2016
  3. 7th EuChemMS Conference on Nitrogen Ligands, Lisbon, Portugal, 2018
Head office

Centrum Badawczo-Rozwojowe “NOVASOME” Sp. z o.o.

Novasome R&D Centre


ul. Olsztyńska 5
51-423 Wrocław

tel. (+48) 71 325 62 42
e-mail: biuro@cbr.novasome.pl

Numer BDO: 000027336
REGON: 933042938
NIP: 8982061354
KRS: 0000225784

Linkedin
Manage your privacy settings
Contact form

The administrator of your personal data provided in the form is the Centrum Badawczo-Rozwojowe "NOVASOME" Sp. z o.o. with its registered office in Wrocław 51-423, ul. Olsztyńska 5. Your personal data will be processed for the purpose of responding to your message. Detailed information on the processing of personal data can be found at https://novasome.pl/polityka-prywatnosci/.

© Copyright 2022 by CBR Novsome sp. z o.o.

Privacy policy

Novasome

Linkedin

 Grupa Hasco

Facebook Linkedin